Showing results (71-80 of 245) with videos related to

Sort By:
Pageof 25
Journal of Gastrointestinal Oncology|March 14, 2024
Regorafenib combined with a PD-1 inhibitor in the second-line setting for unresectable hepatocellular carcinoma in real-world practiceHuaqiang Bi, Jun Pei, Kuansheng Ma, et al.
Critical Reviews in Oncology/Hematology|November 24, 2024
Harnessing tumor metabolism during cancer treatment: A narrative review of emerging dietary approachesNicola Silvestris, Giuseppe Aprile, Dalila Tessitore, et al.
Recenti Progressi in Medicina|January 22, 2026
[CHALLENGE accepted! Exercise in oncology: from "Supportive Care" to "Effective Treatment".]Aureliano Stingi, Giuseppe Aprile, Sara Aspromonte, et al.
Biomedicines|May 28, 2022
Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy EfficacyGerardo Rosati, Giuseppe Aprile, Alfredo Colombo, et al.
Tumori|August 5, 2024
Implementation of a MSRE ddPCR method for the detection of methylated WIF1 and NPY genes in colorectal cancer patientsLuca Trentin, Debora Basile, Elena Lazzari, et al.
Future Oncology (London, England)|September 1, 2016
Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumorsGiuseppe Aprile, Mariaelena Casagrande, Giovanna De Maglio, et al.
The Oncologist|April 25, 2019
Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint InhibitorsAlberto Pavan, Lorenzo Calvetti, Alessandro Dal Maso, et al.
Investigational New Drugs|July 20, 2011
Discontinuation of bevacizumab and FOLFIRI administered up to a maximum of 12 cycles as first-line therapy for metastatic colorectal cancer: a retrospective Italian studyGerardo Rosati, Stefano Cordio, Giuseppe Aprile, et al.
Expert Opinion on Investigational Drugs|May 9, 2014
The challenge of targeted therapies for gastric cancer patients: the beginning of a long journeyGiuseppe Aprile, Riccardo Giampieri, Marta Bonotto, et al.
Advances in Radiation Oncology|October 27, 2025
Are There High-Risk Prognostic Factors for Isolated Locoregional Recurrence in Patients With Early-Stage Breast Cancer Treated With Mastectomy Without Adjuvant Radiation Therapy?Giuseppe Facondo, Chiara Reverberi, Agnese Prisco, et al.
Pageof 25